Pioglitazone for system suitability

Get a Price/Quote

MOQ : 1 Kilograms

Pioglitazone for system suitability Specification

Poisonous
NO

Molecular Weight
392.9 Grams (g)

Purity
92.0%

Grade
Reagent grade.

Molecular Formula
C19H21ClN2O3S

Pioglitazone for system suitability Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms, KG Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
Western Europe, Australia, Eastern Europe, Middle East, Central America, Africa, South America, Asia, North America

Main Domestic Market
All India

About Pioglitazone for system suitability

Pioglitazone for system suitability European Pharmacopoeia (EP) Reference Standard CAS Number 112529-15-4 Empirical Formula (Hill Notation) C19H20N2O3S HCl Molecular Weight 392.90 Synonym: 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride, Pioglitazone hydrochloride Properties InChI Key GHUUBYQTCDQWRA-UHFFFAOYSA-N form neat format neat Description Caution Please find SDS provided by EDQM here. . General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . Packaging Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . Biochem/physiol Actions Pioglitazone hydrochloride is a PPAR agonist and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor (PPAR-) and to a lesser extent PPAR-.